NOVO HOLDINGS A/S Holdings

NOVO HOLDINGS A/S is an investment fund managing more than 2.1B US dollars. The largest holdings include Vanguard Total Stock Market Index Fund, Stryker and Catalent. In Q3 2022 the fund bought assets of total value of 65.53M US dollars and sold assets of total value of 134.06M US dollars.

$2.09B

portfolio value

-4.45%

quarter

-46.98%

1 year

-151.14%

3 years

-151.94%

5 years

NOVO HOLDINGS A/S portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	64789000	19511000
Q2 2016	118812000	73458000
Q3 2016	127529000	25460000
Q4 2016	134255000	52751000
Q1 2017	137058000	287898000
Q2 2017	23072000	183236000
Q3 2017	10457000	70231000
Q4 2017	951000	115944000
Q1 2018	38696000	9484000
Q2 2018	42871000	22063000
Q3 2018	87159000	33576000
Q4 2018	18582000	37945000
Q1 2019	51196000	11804000
Q2 2019	97675000	53749000
Q3 2019	30062000	59472000
Q4 2019	832246000	20966000
Q1 2020	114104000	42850000
Q2 2020	270042000	220541000
Q3 2020	429515000	6665000
Q4 2020	465022000	323215000
Q1 2021	423888000	206596000
Q2 2021	283116000	285990000
Q3 2021	198363000	345458000
Q4 2021	324427000	2610000
Q1 2022	729458000	245903000
Q2 2022	459838000	470356000
Q3 2022	65526000	134064000

NOVO HOLDINGS A/S 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Closed-End Fund - Equity Vanguard Total Stock Market Index Fund Portfolio share: 23.88% Portfolio value: 500.83M Avg. open price: $159.31 Current price: $199.98 P/L: +25.53% Sold -21.12% shares Q1 2022	share	23.88%	500.83M	$159.31	$199.98	+25.53%	Sold -21.12% shares Q1 2022
Medical Devices Stryker Corporation Portfolio share: 7.70% Portfolio value: 161.41M Avg. open price: N/A Current price: $237.9 P/L: N/A N/A Q2 2022	share	7.70%	161.41M	N/A	$237.9	N/A	N/A Q2 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 5.63% Portfolio value: 118.15M Avg. open price: $84.98 Current price: $50.77 P/L: -40.26% Bought +28.40% shares Q2 2022	share	5.63%	118.15M	$84.98	$50.77	-40.26%	Bought +28.40% shares Q2 2022
Asset Management Brookfield Asset Management Inc. Portfolio share: 4.89% Portfolio value: 102.58M Avg. open price: $37.49 Current price: $44.15 P/L: +17.77% Sold -14.12% shares Q3 2022	share	4.89%	102.58M	$37.49	$44.15	+17.77%	Sold -14.12% shares Q3 2022
Semiconductor Equipment & Materials ASML Holding N.V. Portfolio share: 4.49% Portfolio value: 94.18M Avg. open price: $475.88 Current price: $601.13 P/L: +26.32% Bought +5.47% shares Q3 2022	share	4.49%	94.18M	$475.88	$601.13	+26.32%	Bought +5.47% shares Q3 2022
Biotechnology Corcept Therapeutics Incorporated Portfolio share: 4.07% Portfolio value: 85.32M Avg. open price: $23.78 Current price: $23.4 P/L: -1.60% Bought +31.72% shares Q3 2022	share	4.07%	85.32M	$23.78	$23.4	-1.60%	Bought +31.72% shares Q3 2022
Software—Application Salesforce, Inc. Portfolio share: 3.97% Portfolio value: 83.21M Avg. open price: $195.4 Current price: $133.93 P/L: -31.46% Bought +20.90% shares Q3 2022	share	3.97%	83.21M	$195.4	$133.93	-31.46%	Bought +20.90% shares Q3 2022
Medical Devices STERIS plc Portfolio share: 3.71% Portfolio value: 77.76M Avg. open price: N/A Current price: $185.47 P/L: N/A N/A Q2 2022	share	3.71%	77.76M	N/A	$185.47	N/A	N/A Q2 2022
Medical Devices Boston Scientific Corporation Portfolio share: 3.26% Portfolio value: 68.27M Avg. open price: $44.29 Current price: $45.42 P/L: +2.55% Sold -49.76% shares Q3 2022	share	3.26%	68.27M	$44.29	$45.42	+2.55%	Sold -49.76% shares Q3 2022
Telecom Services Cable One, Inc. Portfolio share: 3.25% Portfolio value: 68.26M Avg. open price: $1,353.51 Current price: $729 P/L: -46.14% Bought +79.94% shares Q3 2022	share	3.25%	68.26M	$1,353.51	$729	-46.14%	Bought +79.94% shares Q3 2022
Consumer Electronics Apple Inc. Portfolio share: 3.04% Portfolio value: 63.76M Avg. open price: $72.34 Current price: $146.61 P/L: +102.68% Sold -24.47% shares Q2 2022	share	3.04%	63.76M	$72.34	$146.61	+102.68%	Sold -24.47% shares Q2 2022
Biotechnology Arcellx, Inc. Portfolio share: 2.86% Portfolio value: 59.91M Avg. open price: N/A Current price: $19.45 P/L: N/A Sold -20.54% shares Q3 2022	share	2.86%	59.91M	N/A	$19.45	N/A	Sold -20.54% shares Q3 2022
Biotechnology Edgewise Therapeutics, Inc. Portfolio share: 2.85% Portfolio value: 59.74M Avg. open price: $7.96 Current price: $8.83 P/L: +10.93% Bought +8.67% shares Q3 2022	share	2.85%	59.74M	$7.96	$8.83	+10.93%	Bought +8.67% shares Q3 2022
Semiconductors Taiwan Semiconductor Manufacturing Company Limited Portfolio share: 2.32% Portfolio value: 48.73M Avg. open price: $104.26 Current price: $81.62 P/L: -21.71% Bought +54.93% shares Q2 2022	share	2.32%	48.73M	$104.26	$81.62	-21.71%	Bought +54.93% shares Q2 2022
Internet Retail Alibaba Group Holding Limited Portfolio share: 1.91% Portfolio value: 40.06M Avg. open price: $148.05 Current price: $90.52 P/L: -38.86% Bought +133.13% shares Q4 2021	share	1.91%	40.06M	$148.05	$90.52	-38.86%	Bought +133.13% shares Q4 2021
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 1.69% Portfolio value: 35.38M Avg. open price: N/A Current price: $18.33 P/L: N/A Sold -16.93% shares Q3 2022	share	1.69%	35.38M	N/A	$18.33	N/A	Sold -16.93% shares Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 1.49% Portfolio value: 31.29M Avg. open price: $32.49 Current price: $21.42 P/L: -34.07% Sold -1.72% shares Q3 2022	share	1.49%	31.29M	$32.49	$21.42	-34.07%	Sold -1.72% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 1.28% Portfolio value: 26.91M Avg. open price: N/A Current price: $103.53 P/L: N/A N/A Q2 2022	share	1.28%	26.91M	N/A	$103.53	N/A	N/A Q2 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 1.05% Portfolio value: 21.92M Avg. open price: $13.96 Current price: $12.37 P/L: -11.36% Sold -20.30% shares Q3 2022	share	1.05%	21.92M	$13.96	$12.37	-11.36%	Sold -20.30% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 0.99% Portfolio value: 20.86M Avg. open price: $78.47 Current price: $50.19 P/L: -36.04% Bought +39.18% shares Q2 2022	share	0.99%	20.86M	$78.47	$50.19	-36.04%	Bought +39.18% shares Q2 2022
VECTIVBIO HLDG AG Portfolio share: 0.96% Portfolio value: 20.03M Avg. open price: N/A Current price: N/A P/L: N/A Sold -1.21% shares Q2 2022	share	0.96%	20.03M	N/A	N/A	N/A	Sold -1.21% shares Q2 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.95% Portfolio value: 20.01M Avg. open price: $159.76 Current price: $226.4 P/L: +41.72% Bought +17.92% shares Q3 2022	share	0.95%	20.01M	$159.76	$226.4	+41.72%	Bought +17.92% shares Q3 2022
Biotechnology Vaxcyte, Inc. Portfolio share: 0.94% Portfolio value: 19.76M Avg. open price: N/A Current price: $44.33 P/L: N/A N/A Q2 2022	share	0.94%	19.76M	N/A	$44.33	N/A	N/A Q2 2022
Biotechnology Milestone Pharmaceuticals Inc. Portfolio share: 0.88% Portfolio value: 18.38M Avg. open price: $7.32 Current price: $4.75 P/L: -35.11% Sold -20.95% shares Q3 2022	share	0.88%	18.38M	$7.32	$4.75	-35.11%	Sold -20.95% shares Q3 2022
Health Information Services Minerva Surgical, Inc. Portfolio share: 0.82% Portfolio value: 17.19M Avg. open price: N/A Current price: $0.18 P/L: N/A Sold -9.08% shares Q3 2022	share	0.82%	17.19M	N/A	$0.18	N/A	Sold -9.08% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.79% Portfolio value: 16.58M Avg. open price: $31.81 Current price: $19.89 P/L: -37.47% Bought +9.09% shares Q2 2022	share	0.79%	16.58M	$31.81	$19.89	-37.47%	Bought +9.09% shares Q2 2022
Medical Devices Inari Medical, Inc. Portfolio share: 0.74% Portfolio value: 15.48M Avg. open price: $90.75 Current price: $71.11 P/L: -21.65% Bought +1.52% shares Q3 2022	share	0.74%	15.48M	$90.75	$71.11	-21.65%	Bought +1.52% shares Q3 2022
Biotechnology LAVA Therapeutics N.V. Portfolio share: 0.72% Portfolio value: 15.20M Avg. open price: N/A Current price: $6.17 P/L: N/A N/A Q1 2021	share	0.72%	15.20M	N/A	$6.17	N/A	N/A Q1 2021
Medical Devices Treace Medical Concepts, Inc. Portfolio share: 0.62% Portfolio value: 12.98M Avg. open price: $24.59 Current price: $24.44 P/L: -0.63% Bought +17.56% shares Q2 2022	share	0.62%	12.98M	$24.59	$24.44	-0.63%	Bought +17.56% shares Q2 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 0.59% Portfolio value: 12.40M Avg. open price: $20.43 Current price: $18.32 P/L: -10.32% Bought +48.65% shares Q2 2022	share	0.59%	12.40M	$20.43	$18.32	-10.32%	Bought +48.65% shares Q2 2022
Medical Devices Silk Road Medical, Inc Portfolio share: 0.59% Portfolio value: 12.39M Avg. open price: $49.53 Current price: $53.65 P/L: +8.32% Sold -0.20% shares Q2 2022	share	0.59%	12.39M	$49.53	$53.65	+8.32%	Sold -0.20% shares Q2 2022
Biotechnology Reneo Pharmaceuticals, Inc. Portfolio share: 0.55% Portfolio value: 11.49M Avg. open price: N/A Current price: $2.02 P/L: N/A N/A Q2 2021	share	0.55%	11.49M	N/A	$2.02	N/A	N/A Q2 2021
Biotechnology AbCellera Biologics Inc. Portfolio share: 0.53% Portfolio value: 11.14M Avg. open price: N/A Current price: $11.91 P/L: N/A N/A Q2 2022	share	0.53%	11.14M	N/A	$11.91	N/A	N/A Q2 2022
Biotechnology Nkarta, Inc. Portfolio share: 0.52% Portfolio value: 10.83M Avg. open price: N/A Current price: $8.15 P/L: N/A Sold -62.24% shares Q3 2022	share	0.52%	10.83M	N/A	$8.15	N/A	Sold -62.24% shares Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 0.52% Portfolio value: 10.80M Avg. open price: $231.9 Current price: $234.96 P/L: +1.32% Bought +7.98% shares Q3 2022	share	0.52%	10.80M	$231.9	$234.96	+1.32%	Bought +7.98% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.49% Portfolio value: 10.26M Avg. open price: N/A Current price: $121.22 P/L: N/A N/A Q3 2022	share	0.49%	10.26M	N/A	$121.22	N/A	N/A Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.48% Portfolio value: 10.1M Avg. open price: $27.05 Current price: $19.03 P/L: -29.64% Bought +3.26% shares Q2 2022	share	0.48%	10.1M	$27.05	$19.03	-29.64%	Bought +3.26% shares Q2 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.46% Portfolio value: 9.74M Avg. open price: $18.08 Current price: $7.05 P/L: -61.01% Bought +30.67% shares Q2 2022	share	0.46%	9.74M	$18.08	$7.05	-61.01%	Bought +30.67% shares Q2 2022
Biotechnology Rallybio Corporation Portfolio share: 0.44% Portfolio value: 9.12M Avg. open price: $6.98 Current price: $5.35 P/L: -23.35% Sold -2.19% shares Q3 2022	share	0.44%	9.12M	$6.98	$5.35	-23.35%	Sold -2.19% shares Q3 2022
Biotechnology IO Biotech, Inc. Portfolio share: 0.42% Portfolio value: 8.88M Avg. open price: N/A Current price: $2.81 P/L: N/A N/A Q4 2021	share	0.42%	8.88M	N/A	$2.81	N/A	N/A Q4 2021
Medical Devices Pulmonx Corporation Portfolio share: 0.41% Portfolio value: 8.50M Avg. open price: $32.48 Current price: $6.18 P/L: -80.97% Bought +24.48% shares Q2 2022	share	0.41%	8.50M	$32.48	$6.18	-80.97%	Bought +24.48% shares Q2 2022
Biotechnology Cyteir Therapeutics, Inc. Portfolio share: 0.36% Portfolio value: 7.56M Avg. open price: N/A Current price: $1.36 P/L: N/A Sold -18.59% shares Q3 2022	share	0.36%	7.56M	N/A	$1.36	N/A	Sold -18.59% shares Q3 2022
Biotechnology Spruce Biosciences, Inc. Portfolio share: 0.29% Portfolio value: 6.18M Avg. open price: N/A Current price: $1.17 P/L: N/A Sold -9.52% shares Q2 2021	share	0.29%	6.18M	N/A	$1.17	N/A	Sold -9.52% shares Q2 2021
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.26% Portfolio value: 5.48M Avg. open price: N/A Current price: $1.4 P/L: N/A Sold -17.76% shares Q3 2022	share	0.26%	5.48M	N/A	$1.4	N/A	Sold -17.76% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 0.25% Portfolio value: 5.15M Avg. open price: N/A Current price: $7.07 P/L: N/A N/A Q3 2022	share	0.25%	5.15M	N/A	$7.07	N/A	N/A Q3 2022
Biotechnology Galecto, Inc. Portfolio share: 0.23% Portfolio value: 4.72M Avg. open price: N/A Current price: $1.44 P/L: N/A N/A Q4 2020	share	0.23%	4.72M	N/A	$1.44	N/A	N/A Q4 2020
Biotechnology Pharvaris N.V. Portfolio share: 0.22% Portfolio value: 4.67M Avg. open price: $20.05 Current price: $2.02 P/L: -89.93% Bought +17.46% shares Q3 2022	share	0.22%	4.67M	$20.05	$2.02	-89.93%	Bought +17.46% shares Q3 2022
Biotechnology Galera Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 4.27M Avg. open price: N/A Current price: $1.67 P/L: N/A Sold -16.90% shares Q1 2021	share	0.20%	4.27M	N/A	$1.67	N/A	Sold -16.90% shares Q1 2021
Software—Infrastructure Marqeta, Inc. Portfolio share: 0.15% Portfolio value: 3.14M Avg. open price: N/A Current price: $6.44 P/L: N/A N/A Q4 2021	share	0.15%	3.14M	N/A	$6.44	N/A	N/A Q4 2021
Medical Devices SeaSpine Holdings Corporation Portfolio share: 0.14% Portfolio value: 2.98M Avg. open price: $13.03 Current price: $7.67 P/L: -41.13% Sold -24.30% shares Q3 2022	share	0.14%	2.98M	$13.03	$7.67	-41.13%	Sold -24.30% shares Q3 2022
Biotechnology Aligos Therapeutics, Inc. Portfolio share: 0.10% Portfolio value: 2.14M Avg. open price: N/A Current price: $0.97 P/L: N/A Sold -25.42% shares Q1 2022	share	0.10%	2.14M	N/A	$0.97	N/A	Sold -25.42% shares Q1 2022
Biotechnology Spero Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 938K Avg. open price: $10.6 Current price: $1.89 P/L: -82.17% Sold -18.69% shares Q1 2021	share	0.04%	938K	$10.6	$1.89	-82.17%	Sold -18.69% shares Q1 2021
Medical Devices Inogen, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $95.37 Current price: $21.4 P/L: -77.56% Sold -100.00% shares Q3 2022	share	0.00%	0	$95.37	$21.4	-77.56%	Sold -100.00% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $26.56 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$26.56	N/A	Sold -100.00% shares Q3 2022
Biotechnology Akouos, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $12.02 Current price: $13.29 P/L: +10.60% Sold -100.00% shares Q3 2022	share	0.00%	0	$12.02	$13.29	+10.60%	Sold -100.00% shares Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $5.35 Current price: $13.57 P/L: +153.42% Sold -100.00% shares Q3 2022	share	0.00%	0	$5.35	$13.57	+153.42%	Sold -100.00% shares Q3 2022

Showing TOP 56 NOVO HOLDINGS A/S's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of NOVO HOLDINGS A/S?

The biggest position of the NOVO HOLDINGS A/S is Vanguard Total Stock Market Index Fund (VTI) with 23.88% portfolio share worth of 500.84M US dollars.

Top 5 NOVO HOLDINGS A/S's holdings represent 46.59% of the portfolio:

Vanguard Total Stock Market Index Fund (VTI) – 23.88%
Stryker Corporation (SYK) – 7.7%
Catalent, Inc. (CTLT) – 5.63%
Brookfield Asset Management Inc. (BAM) – 4.89%
ASML Holding N.V. (ASML) – 4.49%

Who is the portfolio manager of NOVO HOLDINGS A/S?

The portfolio manager of the NOVO HOLDINGS A/S is .

What is the total asset value of the NOVO HOLDINGS A/S portfolio?

NOVO HOLDINGS A/S total asset value (portfolio value) is 2.1B US dollars.

Who is ?

is the portfolio manager of the NOVO HOLDINGS A/S.

What is (NOVO HOLDINGS A/S) fund performance?

NOVO HOLDINGS A/S's quarterly performance is -4.45%, annualy -46.98%. In the past 3 years, the value of 's portfolio has decreased by -151%. In the past 5 years, the value of the portfolio has decreased by -152%.

What is the NOVO HOLDINGS A/S CIK?

NOVO HOLDINGS A/S's Central Index Key is 0001388325 .

NOVO HOLDINGS A/S Holdings

NOVO HOLDINGS A/S portfolio value:

NOVO HOLDINGS A/S quarter portfolio value change:

NOVO HOLDINGS A/S 1 year portfolio value change:

NOVO HOLDINGS A/S 3 years portfolio value change:

NOVO HOLDINGS A/S 5 years portfolio value change: